Telecommunications – Interference signal transmission
Patent
1994-10-03
1997-05-13
Zitomer, Stephanie W.
Telecommunications
Interference signal transmission
435 912, 935 77, 935 78, C12Q 168, C12P 1934
Patent
active
056291558
ABSTRACT:
This invention discloses high-affinity oligonucleotide ligands to human Immunoglobulin E (IgE), specifically RNA ligands having the ability to bind to IgE, and the methods for obtaining such ligands. The ligands are capable of inhibiting the interaction of IgE with its receptor.
REFERENCES:
patent: 5270163 (1993-12-01), Gold et al.
Nagpal et al., Autoimmunity 8(1): 59-64 (1990).
Dombrowicz et al. (1993) Cell 75:969-976.
Pieken et al. (1991) Science 253:314-317.
Sutton and Gould (1993) Nature 366:421-428.
Joyce (1989) Gene 82:83.
Joyce and Inoue (1989) Nucleic Acids Research 17:711.
Ellington and Szostak (1990) Abstract of papers presented at the 1990 meeting on RNA Processing, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p. 226.
Kinzler and Vogelstein (1989) Nucleic Acids Research 17:3645.
Kramer et al. (1974) J. Mol. Biol. 89:719.
Levisohn and Spiegelman (1969) Proc. Natl. Acad. SCI. USA 63:805.
Levisohn and Spiegelman Proc. Natl. Acad. Sci. USA 60:866.
Oliphant et al. (1989) Mol. Cell. Biol. 9:2944.
Oliphant and Struhl (1988) Nucleic Acids Research 16:7673.
Oliphant and Struhl (1987) Methods in Enzymology 155:568.
Oliphant et al. (1986) Gene 44:177.
Robertson and Joyce (1990) Nature 344:467.
Thiesen and Bach (1990) Nucleic Acids Research 18:3203.
Chang et al. (1990) Bio/Technology 8:122.
Davis et al. (1991) Bio/Technology 9:53.
Haak-Frendscho et al. (1993) J. Immunology 151:351.
Haba and Nisonoff (1994) Proc. Natl. Acad. Sci. USA 91:604.
Peng et al. (1992) J. Immunology 148:129.
Presta et al. (1993) J. Immunology 151:2623.
Saban et al. (1994) J. Allergy Clin. Immunol. 94:836.
Stampfli et al. (1994) Eur. J. Immunology 24:2161.
Gold Larry
Tasset Diane
Wiegand Torsten W.
NeXstar Pharmaceuticals, Inc.
Zitomer Stephanie W.
LandOfFree
High-affinity oligonucleotide ligands to immunoglobulin E (IgE) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High-affinity oligonucleotide ligands to immunoglobulin E (IgE), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High-affinity oligonucleotide ligands to immunoglobulin E (IgE) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1384347